Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial
Urologic Oncology: Seminars and Original Investigations | May 31, 2018
Most read this week
Urologic Oncology: Seminars and Original Investigations | May 31, 2018